Back
Day Range
$1.00
$1.00
52-Week Range
$1.00
$1.00
Volume
100
50D / 200D Avg
$1.00
/
$1.00
Prev Close
$1.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -111.1 | 0.4 |
| P/B | 729.6 | 2.9 |
| ROE % | -185.0 | 3.7 |
| Net Margin % | -124.2 | 3.9 |
| Rev Growth 5Y % | 84.3 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2026 |
$0.00
$0.00 – $0.00
|
20 M | 0 |
Key Takeaways
Revenue grew 84.33% annually over 5 years — strong growth
Debt/Equity of 0.48 — conservative balance sheet
Negative free cash flow of -9.71M
PEG of 0.05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 90.85%
Capital efficient — spends only 0.34% of revenue on capex
Growth
Revenue Growth (5Y)
84.33%
Revenue (1Y)-6.52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-184.98%
ROIC-338.47%
Net Margin-124.24%
Op. Margin-126.23%
Safety
Debt / Equity
0.48
Current Ratio0.88
Interest Coverage-236.53
Valuation
P/E Ratio
-111.13
P/B Ratio729.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.52% | Revenue Growth (3Y) | 2.44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 84.33% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.67M | Net Income (TTM) | -12.02M |
| ROE | -184.98% | ROA | -194.25% |
| Gross Margin | 40.37% | Operating Margin | -126.23% |
| Net Margin | -124.24% | Free Cash Flow (TTM) | -9.71M |
| ROIC | -338.47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.48 | Current Ratio | 0.88 |
| Interest Coverage | -236.53 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -111.13 | P/B Ratio | 729.57 |
| P/S Ratio | 138.06 | PEG Ratio | 0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.34B | Enterprise Value | 1.34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 9.67M | 10.35M | 9.22M | 1.33M | 837,865.0 |
| Net Income | -12.02M | -11.75M | -7.13M | -7.08M | -6.29M |
| EPS (Diluted) | -0.09 | -0.12 | -0.08 | -0.08 | -0.15 |
| Gross Profit | 3.90M | 6.01M | 6.47M | -240,473.0 | 736,432.0 |
| Operating Income | -12.21M | -6.07M | -4.81M | -5.80M | -5.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 6.19M | 14.86M | 20.80M | 22.97M | 15.63M |
| Total Liabilities | 4.36M | 3.69M | 4.37M | 1.44M | 1.64M |
| Shareholders' Equity | 1.83M | 11.16M | 16.43M | 21.53M | 13.02M |
| Total Debt | 875,189.0 | 532,846.0 | 652,526.0 | 204,038.0 | 481,788.0 |
| Cash & Equivalents | 1.02M | 7.85M | 11.73M | 20.90M | 14.21M |
| Current Assets | 3.70M | 10.50M | 14.72M | 22.24M | 15.19M |
| Current Liabilities | 4.20M | 3.31M | 3.81M | 1.41M | 1.40M |